跳至主要内容
临床试验/NCT00237640
NCT00237640已完成2 期

Effect of Cinnamon on Glucose and Lipid Levels in Non-Insulin Dependent Type 2 Diabetes Mellitus

University of Oklahoma1 个研究点 分布在 1 个国家目标入组 85 人开始时间: 2005年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
85
试验地点
1
主要终点
- Primary outcomes include HbA1c, glucose, total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides levels.

研究概览

简要总结

The purpose of this study is to determine the effects of cinnamon on serum glucose and lipid levels in people with non-insulin dependent type 2 diabetes mellitus.

详细描述

Forty people with non-insulin dependent type 2 diabetes mellitus will be randomized to receive either cinnamon or placebo for three months. The dose of cinnamon will be one gram daily. Fasting serum glucose, triglyceride, total cholesterol, LDL, HDL, and insulin levels will be measured at baseline and at 1, 2, and 3 months. HbA1c levels will be measured at baseline and at 3 months. Patients will be monitored for compliance, adverse effects, and dietary changes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 2 diabetes mellitus
  • HbA1C > 6.0%
  • Age 18 and above
  • Able to obtain consent

排除标准

  • Currently taking insulin
  • Pregnancy
  • End-stage renal disease
  • Hemolytic anemia
  • Cinnamon intolerance
  • Inability or unwillingness to adhere to study protocol

研究组 & 干预措施

1

Placebo Comparator

干预措施: Cinnamon or placebo 500 mg capsule twice daily (Drug)

2

Active Comparator

干预措施: Cinnamon or placebo 500 mg capsule twice daily (Drug)

结局指标

主要结局

- Primary outcomes include HbA1c, glucose, total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides levels.

时间窗: 3 months

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验